<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>BACKGROUND: Postischemic endogenous neurogenesis can be dose-dependently modulated by volatile <z:chebi fb="37" ids="38867">anesthetics</z:chebi> </plain></SENT>
<SENT sid="1" pm="."><plain>The <z:chebi fb="1" ids="38877">intravenous anesthetic</z:chebi> <z:chebi fb="3" ids="44915">propofol</z:chebi> is used during operations with a risk of <z:hpo ids='HP_0002637'>cerebral ischemia</z:hpo>, such as neurosurgery, cardiac surgery, and vascular surgery </plain></SENT>
<SENT sid="2" pm="."><plain>The effects of <z:chebi fb="3" ids="44915">propofol</z:chebi> on neurogenesis are unknown and, therefore, the object of this study </plain></SENT>
<SENT sid="3" pm="."><plain>METHODS: Eighty male Sprague-Dawley rats were randomly assigned to treatment groups with <z:chebi fb="3" ids="44915">propofol</z:chebi> administration for 3 h: 36 mg x kg(-1) x h(-1) <z:chebi fb="3" ids="44915">propofol</z:chebi> with or without <z:hpo ids='HP_0002637'>cerebral ischemia</z:hpo> and 72 mg x kg(-1) x h(-1) <z:chebi fb="3" ids="44915">propofol</z:chebi> with or without <z:hpo ids='HP_0002637'>cerebral ischemia</z:hpo> </plain></SENT>
<SENT sid="4" pm="."><plain>In addition, 7 rats with <z:chebi fb="3" ids="44915">propofol</z:chebi> administration for 6 h and 14 treatment-naive rats were investigated </plain></SENT>
<SENT sid="5" pm="."><plain>Forebrain <z:e sem="disease" ids="C0022116" disease_type="Disease or Syndrome" abbrv="">ischemia</z:e> was induced by bilateral carotid <z:mp ids='MP_0006134'>artery occlusion</z:mp> and hemorrhagic <z:hpo ids='HP_0002615'>hypotension</z:hpo> </plain></SENT>
<SENT sid="6" pm="."><plain>Animals received 5-<z:chebi fb="1" ids="22927,47265">bromo</z:chebi>-2-deoxyuridine for 7 days </plain></SENT>
<SENT sid="7" pm="."><plain>5-<z:chebi fb="1" ids="22927,47265">Bromo</z:chebi>-2-deoxyuridine-positive neurons were counted in the dentate gyrus after 9 and 28 days </plain></SENT>
<SENT sid="8" pm="."><plain>Spatial learning in the Barnes maze and histopathologic damage of the hippocampus were analyzed </plain></SENT>
<SENT sid="9" pm="."><plain>RESULTS: <z:chebi fb="3" ids="44915">Propofol</z:chebi> revealed no impact on basal neurogenesis </plain></SENT>
<SENT sid="10" pm="."><plain><z:hpo ids='HP_0002637'>Cerebral ischemia</z:hpo> increased the amount of new neurons </plain></SENT>
<SENT sid="11" pm="."><plain>After 28 days, neurogenesis significantly increased in animals with low-dose <z:chebi fb="3" ids="44915">propofol</z:chebi> administered during <z:hpo ids='HP_0002637'>cerebral ischemia</z:hpo> compared with naive animals, whereas no significant difference was observed in animals with high-dose <z:chebi fb="3" ids="44915">propofol</z:chebi> during <z:e sem="disease" ids="C0022116" disease_type="Disease or Syndrome" abbrv="">ischemia</z:e> </plain></SENT>
<SENT sid="12" pm="."><plain>Neuronal damage in the CA3 region was increased at 28 days with high-dose <z:chebi fb="3" ids="44915">propofol</z:chebi> </plain></SENT>
<SENT sid="13" pm="."><plain>Postischemic deficits in spatial learning were not affected by <z:chebi fb="3" ids="44915">propofol</z:chebi> </plain></SENT>
<SENT sid="14" pm="."><plain>CONCLUSIONS: Independent effects of <z:chebi fb="3" ids="44915">propofol</z:chebi> are difficult to ascertain </plain></SENT>
<SENT sid="15" pm="."><plain>Peri-ischemic <z:chebi fb="3" ids="44915">propofol</z:chebi> administration may exert secondary effects on neurogenesis by modulating the severity of histopathologic injury and thereby regenerative capacity of the hippocampus </plain></SENT>
</text></document>